These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1763536)

  • 21. Monitoring warfarin therapy in patients with lupus anticoagulants.
    Moll S; Ortel TL
    Ann Intern Med; 1997 Aug; 127(3):177-85. PubMed ID: 9245222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of plasma calibrants in correcting coagulometer effects on international normalized ratios. An international multicenter study.
    Poller L; Triplett DA; Hirsh J; Carroll J; Clarke K
    Am J Clin Pathol; 1995 Mar; 103(3):358-65. PubMed ID: 7872261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring oral anticoagulant treatment with the TAS near-patient test system: comparison with conventional thromboplastins.
    Kitchen S; Preston FE
    J Clin Pathol; 1997 Nov; 50(11):951-6. PubMed ID: 9462248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Monitoring for oral anticoagulant therapy].
    Nakagawa K; Nakahara Y; Tsuji H
    Rinsho Ketsueki; 1995 Apr; 36(4):308-13. PubMed ID: 7783335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accuracy of laboratory and portable monitor international normalized ratio determinations. Comparison with a criterion standard.
    Kaatz SS; White RH; Hill J; Mascha E; Humphries JE; Becker DM
    Arch Intern Med; 1995 Sep; 155(17):1861-7. PubMed ID: 7677552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of native prothrombin antigen with the prothrombin time for monitoring oral anticoagulant prophylaxis.
    Kornberg A; Francis CW; Pellegrini VD; Gabriel KR; Marder VJ
    Circulation; 1993 Aug; 88(2):454-60. PubMed ID: 8339409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring warfarin therapy with the international normalized ratio.
    Howard PA
    Ann Pharmacother; 1994 Feb; 28(2):242-4. PubMed ID: 8173144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of laboratory variation in the prothrombin-time ratio on the results of oral anticoagulant therapy.
    Eckman MH; Levine HJ; Pauker SG
    N Engl J Med; 1993 Sep; 329(10):696-702. PubMed ID: 8135917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cross-Canada survey of prothrombin time testing: Does the establishment of local ISI values improve the accuracy of international normalized ratio reporting? Thrombosis Interest Group of Canada.
    Johnston M; Brigden M
    Am J Clin Pathol; 1998 Nov; 110(5):683-90. PubMed ID: 9802355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticoagulation monitoring part 1: warfarin and parenteral direct thrombin inhibitors.
    Spinler SA; Nutescu EA; Smythe MA; Wittkowsky AK
    Ann Pharmacother; 2005 Jun; 39(6):1049-55. PubMed ID: 15855245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Warfarin monitoring with viscoelastic haemostatic assays, thrombin generation, coagulation factors and correlations to Owren and Quick prothrombin time.
    Nilsson CU; Strandberg K; Reinstrup P
    Scand J Clin Lab Invest; 2018 Sep; 78(5):358-364. PubMed ID: 29792060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Falsely elevated INR results due to the sensitivity of a thromboplastin reagent to heparin.
    Leech BF; Carter CJ
    Am J Clin Pathol; 1998 Jun; 109(6):764-8. PubMed ID: 9620037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving the inter-laboratory harmonization of the international normalized ratio (INR): utilizing the concept of transference to estimate and/or validate international sensitivity index (ISI) and mean normal prothrombin time (MNPT) values and/or to eliminate measurement bias.
    Favaloro EJ; McVicker W; Zhang Y; Hamdam S; Huynh M; Peris P; O'Neal M; Hocker N
    Clin Lab Sci; 2012; 25(1):13-25. PubMed ID: 22458045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral anticoagulant therapy control: evidence that INR expression improves the inter-laboratory comparability of results--the Bologna oral anticoagulant control exercise.
    Palareti G; Coccheri S; Poggi M; Bonetti M; Cervi V; Mazzuca A; Savoia M; Veri L; Fiori F; Gaspari G
    Thromb Haemost; 1987 Oct; 58(3):905-10. PubMed ID: 3433253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin-induced increase in the international normalized ratio. Responses of 10 commercial thromboplastin reagents.
    Solomon HM; Randall JR; Simmons VL
    Am J Clin Pathol; 1995 Jun; 103(6):735-9. PubMed ID: 7785659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Warfarin monitoring independent of the international normalized ratio (INR): a pilot study.
    Carroll WE; Jackson RD
    Res Commun Mol Pathol Pharmacol; 1997 Feb; 95(2):169-78. PubMed ID: 9090753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of a standard and a sensitive thromboplastin in monitoring low intensity oral anticoagulant therapy.
    Brophy MT; Fiore LD; Lau J; Goodwin R; Lopez A; Deykin D
    Am J Clin Pathol; 1994 Jul; 102(1):134-7. PubMed ID: 8037160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Obtaining a reference pattern of rabbit brain thromboplastin].
    Martínez Placencia BM; Lanzetti Theiler MC; Córdova Caballero MS
    Rev Invest Clin; 1989; 41(3):247-52. PubMed ID: 2813999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An international collaborative study on the INR calibration of freeze-dried reference plasmas.
    Hubbard AR; Margetts SM; Weller LJ; Macnab J; Barrowcliffe TW
    Br J Haematol; 1999 Mar; 104(3):455-60. PubMed ID: 10086778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimizing the Verification of Mean Normal Prothrombin Time (MNPT) and International Sensitivity Index (ISI) for Accurate Conversion of Prothrombin Time (PT) to International Normalized Ratio (INR).
    Favaloro EJ
    Methods Mol Biol; 2017; 1646():59-74. PubMed ID: 28804818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.